Physician profile
Emad Jacob
NPI 1669622015
$1,191.38
in general payments reported to CMS, 2019-2025
20 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $37.98 · 2021: $26.44 · 2022: $50.69 · 2023: $457 · 2024: $255 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $939.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $317.53 | 2019-2024 | Lokelma, Farxiga |
| Glaxosmithkline, LLC. | $169.11 | 2022-2025 | Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $141.37 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Ardelyx, INC. | $88.10 | 2024-2025 | Ibsrela |
| Pfizer INC. | $85.88 | 2023-2025 | |
| Amgen INC. | $76.57 | 2023-2025 | Repatha, Otezla, Repatha |
| Abbvie INC. | $49.27 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.56 | 2023-2024 | |
| Lilly USA, LLC | $29.28 | 2023 | Jardiance, Emgality |
| Allergan, INC. | $28.90 | 2019-2020 | |
| Abbott Laboratories | $23.52 | 2022 | |
| Exact Sciences Corporation | $20.55 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $17.62 | 2024 | Verquvo |
| Otsuka America Pharmaceutical, INC. | $16.66 | 2023 | Rexulti |
| Corcept Therapeutics | $16.64 | 2025 | Korlym |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $16.23 | 2023 | Veltassa, Korsuva |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.15 | 2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $15.00 | 2023 | |
| Genentech USA, INC. | $13.58 | 2021 | |
| Horizon Therapeutics Plc | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emad Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.